
9.09BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US9250501064
CUSIP
925050106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.24
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.04
Wall Street Target Price
106.00
EPS Estimate Current Year
0.03
EPS Estimate Next Year
2.49
EPS Estimate Current Quarter
0.105
EPS Estimate Next Quarter
0.285
Most Recent Quarter
-
Revenue TTM
221,672,992
Gross Profit TTM
210,928,000
EBITDA
-52,737,000
Profit Margin
-36.63%
Return On Assets TTM
-6.68%
Return On Equity TTM
-36.36%
Revenue Per Share TTM
2.647
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-1.04
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
35
Price Sales TTM
40.9842
Price Book MRQ
33.0093
Enterprise Value Revenue
40
Enterprise Value EBITDA
-20
256.60
2.91%122.52
1.52%360.85
0.22%1010.26
0.00%121.55
-5.41%235.66
-3.37%31.24
-0.64%99.00
-0.40%58.15
-0.25%959.49
-0.18%Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.
Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.
Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.